Newborn hearing screening rate grows to 15% of population.
This article was originally published in The Gray Sheet
Executive Summary
NEWBORN HEARING SCREENING WITH TEOAE IN PLACE AT 100 HOSPITALS in 25 states, Vince Hutchins, MD, National Center for Education in Maternal and Child Health, said during a briefing on implementation efforts and new technology in the field of newborn hearing loss detection Oct. 11 in Washington D.C. Susan Morgan, MED, Georgetown University Medical Center, said in a video presentation during the briefing that the use of transient evoked otoacoustic emissions (TEOAE) technology "is becoming the standard of care throughout the U.S." for screening infants for hearing impairment.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.